Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Drug Interaction Study of Tasisulam in Patients With Advanced Cancer or Lymphoma

This study has been terminated.
(Terminated based on safety results from another trial)
Information provided by:
Eli Lilly and Company Identifier:
First received: August 18, 2010
Last updated: April 12, 2011
Last verified: April 2011
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2010
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)